© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

North America

  • Ozon, the Russian e-commerce company, completed its IPO on the Nasdaq on Tuesday having built a huge order book for the stock.
  • Singapore-based Tiga Acquisition Corp has raised $240m after increasing the size of its New York Stock Exchange IPO.
  • This week in Keeping Tabs: US treasury secretary Steven Mnuchin asks the Fed to give back emergency funding, bond markets prove their real worth, and why Brexit negotiators need to realise that English isn’t the only language.
  • Chinese cosmetics company Yatsen Holdings saw its shares spike 75% on their New York Stock Exchange debut on Thursday, after the firm priced its IPO at the top of the marketed range.
  • Chinese housing-related platform operator Ke Holdings has raised $2.05bn from a fresh follow-on offering of its New York-listed shares, returning to the equity market less than three months after its IPO.
  • Mexico carried out its largest ever liability management exercise this week, refinancing more than $6.6bn of dollar bonds with new longer dated debt. But deputy finance minister Gabriel Yorio says that the sovereign will remain very active in international bond markets in the short term and is likely to be back in dollars early next year.
  • In the US, stock exchanges have clashed with proxy advisers. Now, those exchanges' German peer Deutsche Börse has bought a majority stake in one of the major advisers, ISS — but says it will ensure the latter's independence.
  • Ford shrugged off its loss of investment grade status to return to the Swiss franc market this week after a 19 year absence to print a three year deal targeted at private bank investors.
  • SSA
    Ontario Teachers’ Finance Trust hit the market on Thursday for the issuer’s first ever green bond — a €750m no-grow 10 year, for which it received an overwhelming response, causing a 7bp tightening.
  • Goldman IBD heads: Lemkau out, Esposito in — UBS whistleblower hired by Therium — New Nordic bosses at Citi's BCMA
  • Syncona, the UK life sciences investor, has launched a new gene therapy company, through a £45m series A private fundraising round. The company could be a future candidate for a lucrative biotech listing.
  • The tripling of Chinese e-commerce firm Pinduoduo’s shares this year did little to deter investors from pouncing on its follow-on and convertible bond outing. It raised about $5.3bn from the combined transactions, paving the way for further expansion and growth.